Scoot and Collinson have announced that all outbound Scoot passengers flying from Singapore, Indonesia and Hong Kong will be able to book COVID-19 pre-departure polymerase chain reaction (RT-PCR) and serology tests as part of a trial service. The service will be run by Collinson – a global leader in the provision of traveller experiences, including medical assistance – and builds upon the pilot recently launched for Singapore Airlines, Scoot’s parent company.
The Collinson online portal will allow customers departing on flights from Singapore, Indonesia and Hong Kong to book pre-departure testing appointments with recognised and accredited partner clinics and digitally receive results within 36 hours. Passengers will be able to access the online portal via the Scoot website or mobile app with email reminders being sent from Scoot after booking.
Passengers will receive their serology test results directly from the clinic; however RT-PCR test results can be obtained through the portal, with QR codes embedded within the RT-PCR result certificates, enabling digital authentication, streamlining verification and strengthening the integrity of the process.
Todd Handcock, Global Chief Commercial Officer & President Asia Pacific at Collinson, added: “We are delighted to further expand our successful partnership with Singapore Airlines by offering COVID-19 pre-departure testing for Scoot passengers. Helping to reopen key routes for travellers in a safe way is our utmost priority and this partnership is another step forward in our aim of achieving the long-term return of global travel. Whilst the roll-out of vaccines is gathering pace across the world, there remains a complex road ahead. With Collinson managing over 190,000 COVID-19 tests to date since the start of the pandemic, we remain dedicated to restoring confidence in travel through the implementation of robust testing protocols across the globe.”
In response to COVID-19, Collinson has shifted its business priorities and has spent the past year applying its global medical assistance expertise to aid the travel industry and help get the world safely travelling again. This has taken shape through a number of collaborative and socially responsible global initiatives with leading airlines, travel and medical bodies – including supporting IATA and Singapore Airlines’ global digital health certificate trials out of the UK and Singapore; launching COVID-19 business solutions designed to help responsible organisations looking to better protect employees who travel and meet for work; and building COVID-19 testing centres at major sites in the UK, including Heathrow, Manchester Airports Group and the O2 Arena. Collinson is now the leading private-sector testing provider in the UK.
